Dr. Hönle (ETR:HNL) reported a stronger second quarter in the first half of its fiscal year, with management saying improved product mix, cost discipline and working capital management helped offset continued weakness in parts of the company’s industrial equipment markets.
Chief Executive Officer Dr. Franz Richter said revenue rose sequentially to EUR 23.8 million in the second quarter from EUR 21.5 million in the first quarter. He said the market environment remained “a little bit difficult,” particularly in plant engineering and mechanical engineering, which weighed on larger systems in the company’s Curing business unit.
